chrX-48765878-G-A
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001080489.3(GLOD5):c.107G>A(p.Arg36His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000092 in 1,195,916 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 34 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001080489.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GLOD5 | NM_001080489.3 | c.107G>A | p.Arg36His | missense_variant | 2/4 | ENST00000303227.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GLOD5 | ENST00000303227.11 | c.107G>A | p.Arg36His | missense_variant | 2/4 | 5 | NM_001080489.3 | P1 | |
GLOD5 | ENST00000445229.1 | c.8G>A | p.Arg3His | missense_variant | 1/3 | 2 | |||
GLOD5 | ENST00000463327.1 | n.147G>A | non_coding_transcript_exon_variant | 2/2 | 2 | ||||
GLOD5 | ENST00000470676.1 | n.100G>A | non_coding_transcript_exon_variant | 2/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000144 AC: 16AN: 110784Hom.: 0 Cov.: 22 AF XY: 0.0000908 AC XY: 3AN XY: 33030
GnomAD3 exomes AF: 0.0000374 AC: 6AN: 160572Hom.: 0 AF XY: 0.0000610 AC XY: 3AN XY: 49144
GnomAD4 exome AF: 0.0000866 AC: 94AN: 1085132Hom.: 0 Cov.: 28 AF XY: 0.0000880 AC XY: 31AN XY: 352322
GnomAD4 genome AF: 0.000144 AC: 16AN: 110784Hom.: 0 Cov.: 22 AF XY: 0.0000908 AC XY: 3AN XY: 33030
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 09, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at